Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Glaucoma: Overview01:25

Glaucoma: Overview

Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Angle Closure Glaucoma: Treatment01:28

Angle Closure Glaucoma: Treatment

Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
Diabetic Retinopathy01:27

Diabetic Retinopathy

DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Letter of response to "Comment re: Comparison of the horizontal diameter to a modeled area of traction in eyes with vitreomacular traction: is the diameter close enough to the truth?"

Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie·2018
Same author

Comparison of the horizontal diameter to a modeled area of traction in eyes with vitreomacular traction: is the diameter close enough to the truth?

Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie·2018
Same author

Anti-VEGF and Beyond.

Journal of ophthalmology·2017
Same author

Demographics of patients receiving Intravitreal anti-VEGF treatment in real-world practice: healthcare research data versus randomized controlled trials.

BMC ophthalmology·2017
Same author

[Orbital emphysema with exophthalmos following transconjunctival pars plana vitrectomy].

Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft·2016
Same author

[Good outcome in Acanthamoeba keratitis].

Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft·2016

Related Experiment Video

Updated: May 24, 2026

Ex Vivo OCT-Based Multimodal Imaging of Human Donor Eyes for Research into Age-Related Macular Degeneration
10:14

Ex Vivo OCT-Based Multimodal Imaging of Human Donor Eyes for Research into Age-Related Macular Degeneration

Published on: May 26, 2023

[Pseudophakic cystoid macular oedema].

T Bertelmann1, M Witteborn, S Mennel

  • 1Augenklinik, Universitätsklinikum Giessen und Marburg GmbH, Marburg, Deutschland. thomas.bertelmann@staff.uni-marburg.de

Klinische Monatsblatter Fur Augenheilkunde
|March 17, 2012
PubMed
Summary

Pseudophakic cystoid macular edema (PCME) remains a concern after cataract surgery, potentially causing vision loss. Early diagnosis and tailored pre/post-operative treatments are crucial for prevention and management.

Area of Science:

  • Ophthalmology
  • Surgical Complications
  • Macular Health

Context:

  • Pseudophakic cystoid macular edema (PCME) persists as a significant clinical issue despite advancements in cataract surgery.
  • High annual surgical volumes contribute to the continued relevance of PCME.
  • PCME can lead to severe, lasting visual impairment even after uneventful procedures.

Purpose:

  • To outline the pathophysiology of PCME, involving inflammation mediators and vitreoretinal changes.
  • To emphasize the importance of pre-surgical risk assessment and management of ocular/systemic conditions.
  • To review diagnostic methods and current treatment strategies for PCME.

Summary:

  • PCME pathophysiology involves surgical induction of inflammation, loss of the lens barrier, mediator action on the macula, and increased vitreoretinal traction.

More Related Videos

Anterior High-Resolution Optical Coherence Tomography in the Diagnosis and Therapeutic Monitoring of Ocular Surface Squamous Neoplasia
06:15

Anterior High-Resolution Optical Coherence Tomography in the Diagnosis and Therapeutic Monitoring of Ocular Surface Squamous Neoplasia

Published on: August 9, 2024

Related Experiment Videos

Last Updated: May 24, 2026

Ex Vivo OCT-Based Multimodal Imaging of Human Donor Eyes for Research into Age-Related Macular Degeneration
10:14

Ex Vivo OCT-Based Multimodal Imaging of Human Donor Eyes for Research into Age-Related Macular Degeneration

Published on: May 26, 2023

Anterior High-Resolution Optical Coherence Tomography in the Diagnosis and Therapeutic Monitoring of Ocular Surface Squamous Neoplasia
06:15

Anterior High-Resolution Optical Coherence Tomography in the Diagnosis and Therapeutic Monitoring of Ocular Surface Squamous Neoplasia

Published on: August 9, 2024

  • Prevention strategies include treating pre-existing conditions, individualized risk assessment, and less traumatic surgical techniques.
  • Diagnosis relies on biomicroscopy, angiography, OCT, and patient symptoms. Treatment options include topical medications (NSAIDs, corticosteroids, carbonic anhydrase inhibitors) and surgical interventions like vitrectomy.
  • Impact:

    • Highlights the need for standardized guidelines for PCME prevention and treatment.
    • Informs clinical practice regarding patient selection, pre-operative optimization, and post-operative care.
    • Underscores the potential for visual impairment and the necessity of prompt, appropriate management.